Schedule 13G ownership disclosure

EPIRUS BIOPHARMACEUTICALS INC

Security class unavailable · CUSIP: 29428P107

Event date: 2015-01-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,500,000
Percent of class
11.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000053417-15-000083
Form type
SC 13G
Filer
EPIRUS Biopharmaceuticals, Inc.
CIK
CIK 1135906
Filed
Feb 10, 2015
Reporting period
Jan 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub